Skip to main content
CORESTEMCHEMON Inc. logo

CORESTEMCHEMON Inc. — Investor Relations & Filings

Ticker · 166480 ISIN · KR7166480004 KO Professional, scientific and technical activities
Open in API
Filings indexed 274 across all filing types
Latest filing 2023-01-31 Director's Dealing
Country KR South Korea
Listing KO 166480

About CORESTEMCHEMON Inc.

https://www.corestemchemon.com/eng/main…

CORESTEMCHEMON Inc. is a biotechnology company operating through two main divisions: a biopharmaceutical unit and a non-clinical Contract Research Organization (CRO) unit. The biopharmaceutical division is dedicated to the research and development of new drugs based on stem cell therapy technology. Its clinical pipeline primarily targets neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), cerebellar ataxia, and multiple sclerosis, as well as autoimmune diseases like systemic lupus erythematosus (SLE) and fibrosis. The non-clinical CRO division provides comprehensive preclinical services, conducting essential toxicity and efficacy evaluations for pharmaceuticals, biopharmaceuticals, cosmetics, and medical devices to support regulatory approval processes.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in Korea. This type of filing is specifically used to report insider transactions, changes in shareholdings, or ownership status by company directors and major shareholders. According to the provided definitions, this falls under 'Director's Dealing' (DIRS).
2023-01-31 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the 'Results of Securities Issuance' (증권 발행결과) for a private placement of exchangeable bonds. It details the issuance amount, payment date, and references previous board resolutions. This falls under the category of capital and financing updates as it relates to the company's capital structure and debt financing activities.
2023-01-26 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 1% confidence The document is a 'Report on the Results of Disposal of Treasury Shares' (자기주식처분결과보고서) filed with the Financial Supervisory Service (금융감독원) in South Korea. It details the specific disposal of treasury shares by Corestem Chemon Co., Ltd. to satisfy exchangeable bond obligations. This falls under the category of a company reporting the sale or disposal of its own shares, which is classified as 'Transaction in Own Shares'.
2023-01-26 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the 'Acquisition of Convertible Bonds before Maturity'. It details specific financial data such as the bond type, acquisition amount, acquisition date, and the reason for the transaction (early repayment and cancellation). This falls under capital structure changes and financing updates, specifically related to debt management. Given the specific nature of the filing regarding the company's capital structure and debt instruments, 'CAP' (Capital/Financing Update) is the most accurate classification.
2023-01-20 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 1% confidence The document is a 'Securities Issuance Result' (증권 발행결과) filing from the Korea Exchange (KRX). It details the final outcome of a private placement of exchangeable bonds (21.5 billion KRW). Since it reports on the completion of a financing activity (issuance of debt securities), it falls under the 'Capital/Financing Update' category.
2023-01-19 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 1% confidence The document is a '자기주식처분결과보고서' (Report on the Results of Disposal of Treasury Shares) filed with the Financial Supervisory Service (금융감독원). It details the specific disposal of treasury shares (2,423,900 shares) related to the issuance of exchangeable bonds. Since this is a formal regulatory filing reporting the execution of a corporate action (disposal of own shares) rather than a simple announcement of a report or a general regulatory notice, it falls under the category of 'Transaction in Own Shares'.
2023-01-19 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.